Chemoinformaics analysis of 1,8-Heptadecadiene-4,6-diyne-3,10-diol
| Molecular Weight | 260.377 | nRot | 8 |
| Heavy Atom Molecular Weight | 236.185 | nRig | 16 |
| Exact Molecular Weight | 260.178 | nRing | 0 |
| Solubility: LogS | -3.534 | nHRing | 0 |
| Solubility: LogP | 3.148 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 43 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 19 | No. of Aromatic Carbocycles | 0 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 24 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 17 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
| nHA | 2 | APOL | 45.997 |
| nHD | 2 | BPOL | 24.077 |
| QED | 0.794 |
| Synth | 3.159 |
| Natural Product Likeliness | 0.631 |
| NR-PPAR-gamma | 0.002 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.234 |
| Pgp-sub | 0.001 |
| HIA | 0.006 |
| CACO-2 | -4.588 |
| MDCK | 0.0000613 |
| BBB | 0.871 |
| PPB | 0.750542 |
| VDSS | 2.578 |
| FU | 0.131946 |
| CYP1A2-inh | 0.105 |
| CYP1A2-sub | 0.87 |
| CYP2c19-inh | 0.18 |
| CYP2c19-sub | 0.935 |
| CYP2c9-inh | 0.026 |
| CYP2c9-sub | 0.444 |
| CYP2d6-inh | 0.97 |
| CYP2d6-sub | 0.902 |
| CYP3a4-inh | 0.125 |
| CYP3a4-sub | 0.512 |
| CL | 12.252 |
| T12 | 0.632 |
| hERG | 0.435 |
| Ames | 0.016 |
| ROA | 0.805 |
| SkinSen | 0.106 |
| Carcinogencity | 0.245 |
| EI | 0.025 |
| Respiratory | 0.633 |
| NR-Aromatase | 0.005 |
| Antiviral | Yes |
| Prediction | 0.832263 |